DaVita(DVA)
Search documents
Diagnosing the Economy Ahead of World Health Day: 6 Picks
Zacks Investment Research· 2024-04-05 13:16
After wrapping up a robust first quarter on strong corporate profits, enthusiasm around AI and hopes that the Fed will cut rates, Wall Street’s rally fizzled out to start Q2 on uncertainty over the timing of rate cuts.Let us examine the health of the U.S. economy ahead on the World Health Day and bring to investors’ attention the key developments and some solid picks for a robust investment portfolio.Similar to the six vital nutrients required for good health, six pillars support the economy. Here, we have ...
DaVita HealthCare (DVA) Is Up 1.09% in One Week: What You Should Know
Zacks Investment Research· 2024-03-21 15:46
Momentum investing is all about the idea of following a stock's recent trend, which can be in either direction. In the 'long' context, investors will essentially be "buying high, but hoping to sell even higher." And for investors following this methodology, taking advantage of trends in a stock's price is key; once a stock establishes a course, it is more than likely to continue moving in that direction. The goal is that once a stock heads down a fixed path, it will lead to timely and profitable trades.Whil ...
4 Stocks Trading Near 52-Week High That Can Climb Further
Zacks Investment Research· 2024-03-21 13:21
Stocks hitting their 52-week high and delivering consistent performance offer attractive opportunities to investors while building a portfolio. This is because stocks near that level are perceived to be winners. However, stocks touching a new 52-week high are often predisposed to profit-taking, resulting in pullbacks and trend reversals.Moreover, given the high price, investors often wonder if the stock is overpriced. While the speculations are not absolutely baseless, all stocks hitting a 52-week high are ...
Why DaVita HealthCare (DVA) is a Top Value Stock for the Long-Term
Zacks Investment Research· 2024-03-15 14:41
It doesn't matter your age or experience: taking full advantage of the stock market and investing with confidence are common goals for all investors. Luckily, Zacks Premium offers several different ways to do both.Featuring daily updates of the Zacks Rank and Zacks Industry Rank, full access to the Zacks #1 Rank List, Equity Research reports, and Premium stock screens, the research service can help you become a smarter, more self-assured investor.It also includes access to the Zacks Style Scores.What are th ...
DaVita HealthCare (DVA) Up 12% Since Last Earnings Report: Can It Continue?
Zacks Investment Research· 2024-03-14 16:36
It has been about a month since the last earnings report for DaVita HealthCare (DVA) . Shares have added about 12% in that time frame, outperforming the S&P 500.Will the recent positive trend continue leading up to its next earnings release, or is DaVita HealthCare due for a pullback? Before we dive into how investors and analysts have reacted as of late, let's take a quick look at its most recent earnings report in order to get a better handle on the important catalysts. DaVita Q4 Earnings & Revenues Top E ...
Best Value Stocks to Buy for March 14th
Zacks Investment Research· 2024-03-14 10:40
Here are three stocks with buy rank and strong value characteristics for investors to consider today, March 14th:International Money Express, Inc. (IMXI) : This money remittance services company carries a Zacks Rank #1 (Strong Buy), and has witnessed the Zacks Consensus Estimate for its current year earnings increasing 5.2% over the last 60 days.International Money Express has a price-to-earnings ratio (P/E) of 9.15, compared with 14.80 for the industry. The company possesses a Value Score of A.Skyward Spec ...
The American Diabetes Association and DaVita Strengthen Alliance to Tackle Chronic Disease Head-On
Prnewswire· 2024-03-11 20:40
Efforts to advance chronic disease prevention through enhanced education, awareness and support — kicking off during National Kidney Month DENVER, March 11, 2024 /PRNewswire/ -- Today, The American Diabetes Association ® (ADA) and DaVita (NYSE: DVA), a leading provider of kidney care services, announced the expansion of a multi-year collaboration, focused on advancing chronic disease prevention, specifically addressing two of the most prevalent chronic conditions in the U.S. — diabetes and chronic kidney di ...
DaVita Inc. to Participate in the Barclays Global Healthcare Conference 2024
PRNewsWire· 2024-03-08 22:20
DENVER, March 8, 2024 /PRNewswire/ -- DaVita Inc. (NYSE: DVA) today announced that its chief financial officer, Joel Ackerman, and its group vice president of investor relations, Nic Eliason, will participate in a fireside chat with investors at Barclays Global Healthcare Conference 2024 on Wednesday, March 13, 2024, at 8:00 a.m. EDT.To view the live webcast, visit the Barclays page and create a free registration.About DaVita Inc.DaVita (NYSE: DVA) is a health care provider focused on transforming care deli ...
Davita (DVA) Shares Gain This Week: Will the Rally Continue?
Zacks Investment Research· 2024-03-08 11:46
Shares of DaVita Inc. (DVA) jumped this week, especially on Tuesday, following an announcement by Novo Nordisk (NVO) that its obesity treatment significantly lowered the mortality risk among patients with chronic kidney disease by 24%. However, the metric failed to cheer Novo Nordisk’s investors, driving dialysis provider DaVita’s shares along with other industry players like Fresenius Medical Care (FMS) Previously, Novo Nordisk halted the so-called FLOW study nearly a year ahead of schedule, achieving its ...
DaVita (DVA) Hits 52-Week High: What's Driving the Stock?
Zacks Investment Research· 2024-03-06 16:11
Shares of DaVita Inc. (DVA) scaled a new 52-week high of $136.29 on Mar 5, before closing the session slightly lower at $134.65.Over the past year, this Zacks Rank #1 (Strong Buy) stock has gained 70.8% compared with the industry’s 22.4% rise and the S&P 500’s 25.4% growth.Over the past five years, the company registered earnings growth of 15.5% compared with the industry’s 5.8% rise. The company’s long-term expected growth rate of 12.1% compares with the industry’s growth projection of 11.2%. DaVita’s earn ...